Clinical trial

Study of Mirtazapine for Agitation in Dementia

NCT03031184

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-01-01

PhasePHASE3

Study timeline

Study start (actual)2017-01-01Date precision: month

Registry last updated2021-04-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Dementiaunresolved

Interventions

MirtazapineDRUG · verified · RxNorm: mirtazapine

Sponsors & collaborators

University of Sussexlead sponsor

Norwich Clinical Trials Unitcollaborator

University of East Angliacollaborator

University of Cambridgecollaborator

University College, Londoncollaborator

London School of Economics and Political Sciencecollaborator

University of Manchestercollaborator

University of Newcastle Upon-Tynecollaborator

Birmingham and Solihull Mental Health NHS Foundation Trustcollaborator

Alzheimer's Societycollaborator

The Centre for Dementia Studies, Brighton and Sussex Medical School and SPFTcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03031184 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.